[1] |
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021, 36(6): 521-545.
|
[2] |
Fernandes das Neves M, Batuca JR, Delgado Alves J. The role of high-density lipoprotein in the regulation of the immune response: implications for atherosclerosis and autoimmunity[J]. Immunology, 2021, 164(2): 231-241.
doi: 10.1111/imm.13348
pmid: 33934336
|
[3] |
Yousefi B, Sanaie S, Ghamari AA, et al. Red cell distribution width as a novel prognostic marker in multiple clinical studies[J]. Indian J Crit Care Med, 2020, 24(1): 49-54.
doi: 10.5005/jp-journals-10071-23328
URL
|
[4] |
段丽钦. 冠心病患者临床特征、外周微循环状态与冠状动脉病变程度的关系[J]. 临床荟萃, 2022, 37(2): 119-123.
|
[5] |
Katsiki N, Dimitriadis GD, Mikhailidis DP. Serum uric acid and diabetes:From pathophysiology to cardiovascular disease[J]. Curr Pharm Des, 2021, 27(16): 1941-1951.
doi: 10.2174/1381612827666210104124320
URL
|
[6] |
张怡, 崔晓冉, 杨晓红. 单核细胞/高密度脂蛋白胆固醇比值在心血管疾病中研究进展[J]. 临床荟萃, 2022, 37(6): 551-555.
|
[7] |
Godo S, Takahashi J, Yasuda S, et al. Role of inflammation in coronary epicardial and microvascular dysfunction[J]. Eur Cardiol, 2021, 16: e13.
|
[8] |
He Q, Zhang P, Li Y, et al. The application of Gensini score and IL-1ra in assessing the condition and prognosis of patients with coronary artery disease[J]. Am J Transl Res, 2021, 13(9): 10421-10427.
pmid: 34650711
|
[9] |
Gabaldon-Perez A, Marcos-Garces V, Gavara J, et al. Coronary revascularization and long-term survivorship in chronic coronary syndrome[J]. J Clin Med, 2021, 10(4): 610.
doi: 10.3390/jcm10040610
URL
|
[10] |
Li Y, Liu X, Luo Y. Monocyte to high-density lipoprotein cholesterol ratio and serum uric acid in Chinese adults: A cross-sectional study[J]. BMC Endocr Disord, 2022, 22(1): 48.
doi: 10.1186/s12902-022-00966-z
pmid: 35216583
|
[11] |
Liu H, Zhan F, Wang Y. Evaluation of monocyte-to-high-density lipoprotein cholesterol ratio and monocyte-to-lymphocyte ratio in ischemic stroke[J]. J Int Med Res, 2020, 48(7): 300060520933806.
|
[12] |
Emmens JE, Jia C, Ng LL, et al. Impaired high-density lipoprotein function in patients with heart failure[J]. J Am Heart Assoc, 2021, 10(9): e019123.
|
[13] |
Jia C, Anderson JLC, Gruppen EG, et al. High-density lipoprotein anti-inflammatory capacity and incident cardiovascular events[J]. Circulation, 2021, 143(20): 1935-1945.
doi: 10.1161/CIRCULATIONAHA.120.050808
pmid: 33840204
|
[14] |
Kalyoncuoglu M, Biter Hİ, Ozturk S, et al. Predictive accuracy of lymphocyte-to-monocyte ratio and monocyte-to-high-density-lipoprotein-cholesterol ratio in determining the slow flow/no-reflow phenomenon in patients with non-ST-elevated myocardial infarction[J]. Coron Artery Dis, 2020, 31(6): 518-526.
|
[15] |
Villanueva DLE, Tiongson MD, Ramos JD, et al. Monocyte to high-density lipoprotein ratio (MHR) as a predictor of mortality and major adverse cardiovascular events (MACE) among ST elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention: A meta-analysis[J]. Lipids Health Dis, 2020, 19(1): 55.
doi: 10.1186/s12944-020-01242-6
pmid: 32216795
|
[16] |
Chen BW, Liu JJ, Xing JH, et al. Analysis of the correlation between the ratio of monocytes to high-density lipoprotein cholesterol and in-stent restenosis in patients with premature coronary heart disease[J]. Clin Appl Thromb Hemost, 2022, 28: 10760296221079334.
|
[17] |
Turgay Yıldırım Ö, Aydın F, Hüseyinoˇglu Aydın A, et al. Red cell distribution width and its prediction value of mortality[J]. Heart Lung, 2020, 49(2): 205.
doi: S0147-9563(19)30522-9
pmid: 31679803
|
[18] |
Ferreira JP, Lamiral Z, Bakris G, et al. Red cell distribution width in patients with diabetes and myocardial infarction: An analysis from the EXAMINE trial[J]. Diabetes Obes Metab, 2021, 23(7): 1580-1587.
doi: 10.1111/dom.14371
pmid: 33687751
|
[19] |
Zhang M, Wu S, Xu S, et al. Impact of monocyte to high-density lipoprotein ratio on the identification of prevalent coronary heart disease: insights from a general population[J]. Postgrad Med, 2021, 133(7): 822-829.
doi: 10.1080/00325481.2021.1957265
pmid: 34281466
|
[20] |
Lorkowski SW, Smith JD. HDL is not dead yet[J]. Biomedicines, 2022, 10(1): 128.
doi: 10.3390/biomedicines10010128
URL
|
[21] |
Xiang L, Zhang M, Wu H, et al. The expression and prognostic value of ischemia modified albumin (IMA), red blood cell distribution width (RDW), and lipoprotein (LP) in patients with diabetes mellitus complicated with coronary heart disease[J]. Ann Palliat Med, 2021, 10(4): 4463-4471.
doi: 10.21037/apm
URL
|
[22] |
孔祥勇, 余华, 冯克福, 等. 单核细胞与高密度脂蛋白胆固醇比值在冠心病合并高尿酸血症患者中的变化及其与冠心病患者冠状动脉狭窄程度的关系研究[J]. 实用心脑肺血管病杂志, 2020, 28(7): 37-40+53.
|
[23] |
Guo G, Huang Z, Wang S, et al. Sex differences in uric acid and NT-pro BNP assessments during coronary severity[J]. Medicine (Baltimore), 2020, 99(15): e19653.
|
[24] |
Çanga Y, Emre A, Karataş MB, et al. Prognostic value of serum uric acid levels in patients with non-STEMI undergoing percutaneous coronary intervention[J]. Herz, 2020, 45(4): 389-396.
doi: 10.1007/s00059-019-04849-3
pmid: 31485775
|
[25] |
Kumbhalkar S, Deotale R. Association between Serum uric acid level with presence and severity of coronary artery disease[J]. J Assoc Physicians India, 2019, 67(4): 29-32.
pmid: 31311215
|